Global Neurotechnology Market Overview

The Global Neurotechnology Market size is expected to grow from USD 12.88 billion in 2022 to USD 30.92 billion by 2030, at a CAGR of 11.57% during the forecast period (2023-2030).

Neurotechnology is an innovative technology that is used to monitor neural activity. This technology is integrated with electronic device to repair, control, and improve brain functions. The neurotechnologies have common design goals consisting of controlling external devices like neuroprosthetics by using neural activity readings, through neuromodulation changes the neural activity to repair the neural functions affected by neurological disorders. Example of neurotechnologies contains photo stimulation based on optogenetics and phytopharmacology, deep brain stimulation, transcranial magnetic stimulation, and brain-computer interfaces, like cochlear implants and retinal implants. Various advanced neurotechnology such as brain mapping techniques, novel osteogenic implants, microfluidic technologies, and neuromodulation technologies are used for the treatment of neurological disorders. The growing prevalence of neurological disorders is anticipated to support the development of the neurotechnology market over the forecasted period.

Market Dynamics And Factors For Neurotechnology Market

Drivers:

Rising Incidences and The Prevalence of The Neurological Disorders

The growing prevalence of disease-related neurology such as Stroke, Alzheimer's Disease, Epilepsy, Parkinson’s, Multiple Sclerosis, Migraines, and Meningitis is the key factor that supported the growth of the market. According to WHO, 15 million people experience strokes every year. Stroke is caused due to various factors including smoking, high blood pressure, high cholesterol level, and diabetes. Dementia is one of the neurological diseases that cause the loss of memory, and language, and problems interfere with daily life more than 55 million people were living with dementia in 2020. Alzheimer’s disease is a common type of dementia.

According to Statista, 6.1 million people were affected by Alzheimer's Disease in the year 2020. Parkinson's disease is the second most common neurological disorder after Alzheimer's, affecting 7–10 million individuals worldwide each year. According to Statista, Japan has the population with the highest percentage of senior citizens. Most cases of neurological diseases are found in older people. Thus, the growing prevalence of neurological disorders and rising demand for various neurotechnology for diagnosis purposes propels the growth of the neurotechnology market.

Restraints:

Present Technologies Are Far From Being Highly Scalable

Despite their potential, current neurotechnologies are far from reliable enough for use in daily work and life. Existing systems frequently and repeatedly make errors in decoding users' mental states or intentions from their neurophysiological signals. This low reliability can be attributed to a variety of factors, including imperfect neurophysiological sensors, particularly Electroencephalography (EEG) and functional Near Infrared Spectroscopy (fNIRS), which only record data with low Signal-to-Noise-Ratio (SNR). These physiological signals are extremely sensitive to systemic artifacts originating from non-neuronal sources, such as muscles (Electromyography), eyes (Electrooculography), motions for EEG, or from various light sources or motions for fNIRS, or from the environment itself. This deterioration of neurophysiological signals due to artifacts is even more pronounced in real-life situations with potentially mobile users and noisy environments, which is also the target use case of Neuroergonomics thus, hampering the development of the neurotechnology market over the forecasted period.

Opportunity:

Lucrative Opportunity in The Use of Advanced Technology In the Neurotechnology

The various innovative technology used in neurotechnology improves the efficiency of the neurotechnology which provide a huge opportunity for the market during the forecast period.

The adoption of new neurotechnologies such as biohybrid neuronics and in-vivo optogenetics is increased to improve neurological disorders. Optogenetics is one of the novel technologies that modulate neuron activities. Moreover, the use of MEMS, and AI in neurotechnology to improve efficiency. Owing to the prevalence of chronic neurological disorders the key players and government of various countries rising their investment in the research and development of novel neurotechnology that offers a remunerative opportunity for the neurotechnology market in the projected timeframe.

Segmentation Analysis Of The Neurotechnology Market

By Type, Neurostimulation is expected to have the maximum market share in neurotechnology. Neurostimulation is the most popular and purposeful modulation for monitoring the activity of the nervous system. It is the technology that improves the quality of those people who suffer from severe paralyzing, losses various sense organs, and permanent reduction of severe chronic pain. Neurostimulation therapies contain invasive and noninvasive approaches which consist of electrical stimulation application to improve the neural function within a circuit. The neurostimulation devices include a deep brain stimulator, transcutaneous electrical nerve stimulation [TENS], a spinal cord stimulator, and a vagus nerve stimulator. The demand for neurostimulation devices is rising due to the growing prevalence of the lifestyle diseases such as chronic pain, depression, urinary and fecal incontinence, essential tremor, and other neurological disorders. Moreover, High investment in neurological R&D by researchers and market players from various countries. For instance, in January 2021, Abbott launched Neuso Spheremy Path to track and report on patient-perceived pain relief. Additionally, neurostimulators are also used for interstitial cystitis, obsessive-compulsive disorders, and asthma. The growing geriatric population and major players emphasize technological advancement that provides growth for the neurotechnology market.

By Application, diagnosis holds the largest share of the neurotechnology market. The diagnosis of neurological disorders helps doctors to decide the option for treatment and prevent future health risks to patients. The physician and researcher use various diagnostic imaging techniques, chemicals, and metabolic tests for the detection, management, and treatment of neurological diseases. The diagnostic test includes a CT scan, electroencephalogram (EEG), MRI, electromyography, nerve conductive velocity, position emission tomography (PET), arteriogram, spinal tap, myelogram, ultrasound, and other tests. These diagnostic tests help to detect the cancer disease type and monitor its progression, through which physicians can take decisions about the proper treatment of a disease. The diagnostic test is performed in the hospital as well as diagnostic centers. The growing incidence of neurologic disorder, and growing research and development activity that helps to increase the number of diagnostic centers that provides the growth for neurotechnology market.

Regional Analysis Of The Neurotechnology Market

North America is the dominating country in the neurotechnology market owing to the growing prevalence of neurological disorders. The rising aging population, unhealthy eating habits, and hectic lifestyles are the common causes of neurological disorders. According to Statista, 32.51 million people smoked cigarettes in 2020. Cigarette smoking is the major cause of neurological disorders. The following figure shows the number of Parkinson's disease deaths in the U.S. in 2020 by state.

Moreover, about 60,000 Americans are diagnosed with Parkinson’s disease. For the treatment of such neurological disorders, the demand for neurotechnology is increased from the hospital as well as diagnostic centers in this region. Therefore, the research center and governments of the various countries of this region increase their investment in the research and development activity of neurotechnology that supports the growth of the neurotechnology market over the forecast period.

The Asia Pacific is the second-dominated region in the neurotechnology market owing to the large population base with the highest number of people living with neurological disorders. The aging population of the APAC region is rapidly growing. Thus, the number of cases of neurological disorder is also increased. By Statista, in China, there are 81% of the population suffers from psychological disorders and about 10 million people live with epilepsy. APAC is a developing region, thereby increasing the adoption of unhealthy habits, and poor diets cause neurological disorders. Additionally, peoples in this region live hectic lifestyles is the main cause of migraine, strokes, and depression. Thus, the population with neurological diseases is increasing in this region. Moreover, the high investment by the government and major key players of neurotechnology in the research and development of the new technology provides the opportunity for increasing the neurotechnology market during the forecast period.

Europe has significant growth in the neurotechnology market due to the growing prevalence of neurological disorders. Peoples in this region live with unhealthy habits like consumption of alcohol, smoking, and hectic lifestyle that support an increase in the prevalence of neurological disease. For instance, Statista stated that in 2021, there were 2.7 million people in Italy suffering from neurological disorders. Thus, the adoption of neurotechnology in diagnostic, hospitals, and clinics is increased. Therefore, the government and research centers in this region more spend on the development of novel neurotechnology that provides growth for the neurotechnology market of this region.

Covid-19 Impact Analysis On Neurotechnology Market

COVID-19 began in Wuhan (China) in December 2019 and has since rapidly grown around the globe. In terms of confirmed cases and reported deaths, the US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are among the countries that have been most severely impacted. Because of the lockdowns, travel restrictions, and business closures, COVID-19 has had an impact on the businesses and industries of numerous nations. The covid-19 has had a positive impact on the healthcare system. During the pandemic, the pharmaceutical industries engaged in research and development activity. Thus, growing demand for neurotechnology in the healthcare sector. Because of the covid-19 burden people suffering from memory disturbances, and migraines. The neurological symptoms include headaches, loss of taste, and smell, stroke, brain inflammation, sleep disorders, and delirium. Thus, the adoption of neurotechnology during the pandemic is increased. Henceforth COVID-19 has had a positive impact on the neurotechnology market.

Top Key Players Covered In Neurotechnology Market

• General Electric Company (The U.S)
• Siemens Healthineers (Germany)
• Koninklijke Philips N.V. (Netherlands)
• Toshiba Medical Systems Corporation (Japan)
• Shimadzu Corporation (Japan)
• Hitachi Medical Corporation (Japan)
• Elekta AB (Sweden)
• Tristan Technologies, Inc. (The U.S)
• Natus Medical Incorporated (The U.S)
• Magstim (UK), and other major players.

Key Industry Development In The Neurotechnology Market

In September 2021, Food and Drug Administration (FDA) Approves the Amplatzer Talisman Patent Foramen ovale (PFO) Occlusion System developed by Abbott for patients with recurrent ischemic stroke. This helps to develop the efficiency and effectiveness of the occlusion procedure in a faster and simpler manner.

In April 2022, Natus Medical Inc. is acquired by ArchiMed, a leading investment company for the healthcare industry for USD 1.2 billion. The purpose of the acquisition is to deliver valuable services to its customers.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Product Type
 3.2 By Technology
 3.3 By Usability
 3.4 By Application

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Neurotechnology Market by Product Type
 5.1 Neurotechnology Market Overview Snapshot and Growth Engine
 5.2 Neurotechnology Market Overview
 5.3 Linear Staplers
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Linear Staplers: Geographic Segmentation
 5.4 Circular Staplers
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Circular Staplers: Geographic Segmentation
 5.5 Skin Staplers
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Skin Staplers: Geographic Segmentation
 5.6 Endoscopic Staplers
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Endoscopic Staplers: Geographic Segmentation
 5.7 Others
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size (2016-2028F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Others: Geographic Segmentation

Chapter 6: Neurotechnology Market by Technology
 6.1 Neurotechnology Market Overview Snapshot and Growth Engine
 6.2 Neurotechnology Market Overview
 6.3 Manual
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Manual: Geographic Segmentation
 6.4 Powered
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Powered: Geographic Segmentation

Chapter 7: Neurotechnology Market by Usability
 7.1 Neurotechnology Market Overview Snapshot and Growth Engine
 7.2 Neurotechnology Market Overview
 7.3 Disposable
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Disposable: Geographic Segmentation
 7.4 Reusable
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Reusable: Geographic Segmentation

Chapter 8: Neurotechnology Market by Application
 8.1 Neurotechnology Market Overview Snapshot and Growth Engine
 8.2 Neurotechnology Market Overview
 8.3 General Surgery
  8.3.1 Introduction and Market Overview
  8.3.2 Historic and Forecasted Market Size (2016-2028F)
  8.3.3 Key Market Trends, Growth Factors and Opportunities
  8.3.4 General Surgery: Geographic Segmentation
 8.4 Abdominal & Pelvic Surgery
  8.4.1 Introduction and Market Overview
  8.4.2 Historic and Forecasted Market Size (2016-2028F)
  8.4.3 Key Market Trends, Growth Factors and Opportunities
  8.4.4 Abdominal & Pelvic Surgery: Geographic Segmentation
 8.5 Cardiac & Thoracic Surgery
  8.5.1 Introduction and Market Overview
  8.5.2 Historic and Forecasted Market Size (2016-2028F)
  8.5.3 Key Market Trends, Growth Factors and Opportunities
  8.5.4 Cardiac & Thoracic Surgery: Geographic Segmentation
 8.6 Orthopedic Surgery
  8.6.1 Introduction and Market Overview
  8.6.2 Historic and Forecasted Market Size (2016-2028F)
  8.6.3 Key Market Trends, Growth Factors and Opportunities
  8.6.4 Orthopedic Surgery: Geographic Segmentation
 8.7 Others
  8.7.1 Introduction and Market Overview
  8.7.2 Historic and Forecasted Market Size (2016-2028F)
  8.7.3 Key Market Trends, Growth Factors and Opportunities
  8.7.4 Others: Geographic Segmentation

Chapter 9: Company Profiles and Competitive Analysis
 9.1 Competitive Landscape
  9.1.1 Competitive Positioning
  9.1.2 Neurotechnology Sales and Market Share By Players
  9.1.3 Industry BCG Matrix
  9.1.4 Heat Map Analysis
  9.1.5 Neurotechnology Industry Concentration Ratio (CR5 and HHI)
  9.1.6 Top 5 Neurotechnology Players Market Share
  9.1.7 Mergers and Acquisitions
  9.1.8 Business Strategies By Top Players
 9.2 GENERAL ELECTRIC COMPANY
  9.2.1 Company Overview
  9.2.2 Key Executives
  9.2.3 Company Snapshot
  9.2.4 Operating Business Segments
  9.2.5 Product Portfolio
  9.2.6 Business Performance
  9.2.7 Key Strategic Moves and Recent Developments
  9.2.8 SWOT Analysis
 9.3 SIEMENS HEALTHINEERS
 9.4 KONINKLIJKE PHILIPS N.V.
 9.5 TOSHIBA MEDICAL SYSTEMS CORPORATION
 9.6 SHIMADZU CORPORATION
 9.7 HITACHI MEDICAL CORPORATION
 9.8 ELEKTA AB
 9.9 TRISTAN TECHNOLOGIES
 9.10 INC.
 9.11 NATUS MEDICAL INCORPORATED
 9.12 MAGSTIM
 9.13 OTHER MAJOR PLAYERS

Chapter 10: Global Neurotechnology Market Analysis, Insights and Forecast, 2016-2028
 10.1 Market Overview
 10.2 Historic and Forecasted Market Size By Product Type
  10.2.1 Linear Staplers
  10.2.2 Circular Staplers
  10.2.3 Skin Staplers
  10.2.4 Endoscopic Staplers
  10.2.5 Others
 10.3 Historic and Forecasted Market Size By Technology
  10.3.1 Manual
  10.3.2 Powered
 10.4 Historic and Forecasted Market Size By Usability
  10.4.1 Disposable
  10.4.2 Reusable
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 General Surgery
  10.5.2 Abdominal & Pelvic Surgery
  10.5.3 Cardiac & Thoracic Surgery
  10.5.4 Orthopedic Surgery
  10.5.5 Others

Chapter 11: North America Neurotechnology Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Product Type
  11.4.1 Linear Staplers
  11.4.2 Circular Staplers
  11.4.3 Skin Staplers
  11.4.4 Endoscopic Staplers
  11.4.5 Others
 11.5 Historic and Forecasted Market Size By Technology
  11.5.1 Manual
  11.5.2 Powered
 11.6 Historic and Forecasted Market Size By Usability
  11.6.1 Disposable
  11.6.2 Reusable
 11.7 Historic and Forecasted Market Size By Application
  11.7.1 General Surgery
  11.7.2 Abdominal & Pelvic Surgery
  11.7.3 Cardiac & Thoracic Surgery
  11.7.4 Orthopedic Surgery
  11.7.5 Others
 11.8 Historic and Forecast Market Size by Country
  11.8.1 U.S.
  11.8.2 Canada
  11.8.3 Mexico

Chapter 12: Europe Neurotechnology Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Product Type
  12.4.1 Linear Staplers
  12.4.2 Circular Staplers
  12.4.3 Skin Staplers
  12.4.4 Endoscopic Staplers
  12.4.5 Others
 12.5 Historic and Forecasted Market Size By Technology
  12.5.1 Manual
  12.5.2 Powered
 12.6 Historic and Forecasted Market Size By Usability
  12.6.1 Disposable
  12.6.2 Reusable
 12.7 Historic and Forecasted Market Size By Application
  12.7.1 General Surgery
  12.7.2 Abdominal & Pelvic Surgery
  12.7.3 Cardiac & Thoracic Surgery
  12.7.4 Orthopedic Surgery
  12.7.5 Others
 12.8 Historic and Forecast Market Size by Country
  12.8.1 Germany
  12.8.2 U.K.
  12.8.3 France
  12.8.4 Italy
  12.8.5 Russia
  12.8.6 Spain
  12.8.7 Rest of Europe

Chapter 13: Asia-Pacific Neurotechnology Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Product Type
  13.4.1 Linear Staplers
  13.4.2 Circular Staplers
  13.4.3 Skin Staplers
  13.4.4 Endoscopic Staplers
  13.4.5 Others
 13.5 Historic and Forecasted Market Size By Technology
  13.5.1 Manual
  13.5.2 Powered
 13.6 Historic and Forecasted Market Size By Usability
  13.6.1 Disposable
  13.6.2 Reusable
 13.7 Historic and Forecasted Market Size By Application
  13.7.1 General Surgery
  13.7.2 Abdominal & Pelvic Surgery
  13.7.3 Cardiac & Thoracic Surgery
  13.7.4 Orthopedic Surgery
  13.7.5 Others
 13.8 Historic and Forecast Market Size by Country
  13.8.1 China
  13.8.2 India
  13.8.3 Japan
  13.8.4 Singapore
  13.8.5 Australia
  13.8.6 New Zealand
  13.8.7 Rest of APAC

Chapter 14: Middle East & Africa Neurotechnology Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Product Type
  14.4.1 Linear Staplers
  14.4.2 Circular Staplers
  14.4.3 Skin Staplers
  14.4.4 Endoscopic Staplers
  14.4.5 Others
 14.5 Historic and Forecasted Market Size By Technology
  14.5.1 Manual
  14.5.2 Powered
 14.6 Historic and Forecasted Market Size By Usability
  14.6.1 Disposable
  14.6.2 Reusable
 14.7 Historic and Forecasted Market Size By Application
  14.7.1 General Surgery
  14.7.2 Abdominal & Pelvic Surgery
  14.7.3 Cardiac & Thoracic Surgery
  14.7.4 Orthopedic Surgery
  14.7.5 Others
 14.8 Historic and Forecast Market Size by Country
  14.8.1 Turkey
  14.8.2 Saudi Arabia
  14.8.3 Iran
  14.8.4 UAE
  14.8.5 Africa
  14.8.6 Rest of MEA

Chapter 15: South America Neurotechnology Market Analysis, Insights and Forecast, 2016-2028
 15.1 Key Market Trends, Growth Factors and Opportunities
 15.2 Impact of Covid-19
 15.3 Key Players
 15.4 Key Market Trends, Growth Factors and Opportunities
 15.4 Historic and Forecasted Market Size By Product Type
  15.4.1 Linear Staplers
  15.4.2 Circular Staplers
  15.4.3 Skin Staplers
  15.4.4 Endoscopic Staplers
  15.4.5 Others
 15.5 Historic and Forecasted Market Size By Technology
  15.5.1 Manual
  15.5.2 Powered
 15.6 Historic and Forecasted Market Size By Usability
  15.6.1 Disposable
  15.6.2 Reusable
 15.7 Historic and Forecasted Market Size By Application
  15.7.1 General Surgery
  15.7.2 Abdominal & Pelvic Surgery
  15.7.3 Cardiac & Thoracic Surgery
  15.7.4 Orthopedic Surgery
  15.7.5 Others
 15.8 Historic and Forecast Market Size by Country
  15.8.1 Brazil
  15.8.2 Argentina
  15.8.3 Rest of SA

Chapter 16 Investment Analysis

Chapter 17 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. NEUROTECHNOLOGY MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. NEUROTECHNOLOGY MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. NEUROTECHNOLOGY MARKET COMPETITIVE RIVALRY
TABLE 005. NEUROTECHNOLOGY MARKET THREAT OF NEW ENTRANTS
TABLE 006. NEUROTECHNOLOGY MARKET THREAT OF SUBSTITUTES
TABLE 007. NEUROTECHNOLOGY MARKET BY PRODUCT TYPE
TABLE 008. LINEAR STAPLERS MARKET OVERVIEW (2016-2028)
TABLE 009. CIRCULAR STAPLERS MARKET OVERVIEW (2016-2028)
TABLE 010. SKIN STAPLERS MARKET OVERVIEW (2016-2028)
TABLE 011. ENDOSCOPIC STAPLERS MARKET OVERVIEW (2016-2028)
TABLE 012. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 013. NEUROTECHNOLOGY MARKET BY TECHNOLOGY
TABLE 014. MANUAL MARKET OVERVIEW (2016-2028)
TABLE 015. POWERED MARKET OVERVIEW (2016-2028)
TABLE 016. NEUROTECHNOLOGY MARKET BY USABILITY
TABLE 017. DISPOSABLE MARKET OVERVIEW (2016-2028)
TABLE 018. REUSABLE MARKET OVERVIEW (2016-2028)
TABLE 019. NEUROTECHNOLOGY MARKET BY APPLICATION
TABLE 020. GENERAL SURGERY MARKET OVERVIEW (2016-2028)
TABLE 021. ABDOMINAL & PELVIC SURGERY MARKET OVERVIEW (2016-2028)
TABLE 022. CARDIAC & THORACIC SURGERY MARKET OVERVIEW (2016-2028)
TABLE 023. ORTHOPEDIC SURGERY MARKET OVERVIEW (2016-2028)
TABLE 024. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 025. NORTH AMERICA NEUROTECHNOLOGY MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 026. NORTH AMERICA NEUROTECHNOLOGY MARKET, BY TECHNOLOGY (2016-2028)
TABLE 027. NORTH AMERICA NEUROTECHNOLOGY MARKET, BY USABILITY (2016-2028)
TABLE 028. NORTH AMERICA NEUROTECHNOLOGY MARKET, BY APPLICATION (2016-2028)
TABLE 029. N NEUROTECHNOLOGY MARKET, BY COUNTRY (2016-2028)
TABLE 030. EUROPE NEUROTECHNOLOGY MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 031. EUROPE NEUROTECHNOLOGY MARKET, BY TECHNOLOGY (2016-2028)
TABLE 032. EUROPE NEUROTECHNOLOGY MARKET, BY USABILITY (2016-2028)
TABLE 033. EUROPE NEUROTECHNOLOGY MARKET, BY APPLICATION (2016-2028)
TABLE 034. NEUROTECHNOLOGY MARKET, BY COUNTRY (2016-2028)
TABLE 035. ASIA PACIFIC NEUROTECHNOLOGY MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 036. ASIA PACIFIC NEUROTECHNOLOGY MARKET, BY TECHNOLOGY (2016-2028)
TABLE 037. ASIA PACIFIC NEUROTECHNOLOGY MARKET, BY USABILITY (2016-2028)
TABLE 038. ASIA PACIFIC NEUROTECHNOLOGY MARKET, BY APPLICATION (2016-2028)
TABLE 039. NEUROTECHNOLOGY MARKET, BY COUNTRY (2016-2028)
TABLE 040. MIDDLE EAST & AFRICA NEUROTECHNOLOGY MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 041. MIDDLE EAST & AFRICA NEUROTECHNOLOGY MARKET, BY TECHNOLOGY (2016-2028)
TABLE 042. MIDDLE EAST & AFRICA NEUROTECHNOLOGY MARKET, BY USABILITY (2016-2028)
TABLE 043. MIDDLE EAST & AFRICA NEUROTECHNOLOGY MARKET, BY APPLICATION (2016-2028)
TABLE 044. NEUROTECHNOLOGY MARKET, BY COUNTRY (2016-2028)
TABLE 045. SOUTH AMERICA NEUROTECHNOLOGY MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 046. SOUTH AMERICA NEUROTECHNOLOGY MARKET, BY TECHNOLOGY (2016-2028)
TABLE 047. SOUTH AMERICA NEUROTECHNOLOGY MARKET, BY USABILITY (2016-2028)
TABLE 048. SOUTH AMERICA NEUROTECHNOLOGY MARKET, BY APPLICATION (2016-2028)
TABLE 049. NEUROTECHNOLOGY MARKET, BY COUNTRY (2016-2028)
TABLE 050. GENERAL ELECTRIC COMPANY: SNAPSHOT
TABLE 051. GENERAL ELECTRIC COMPANY: BUSINESS PERFORMANCE
TABLE 052. GENERAL ELECTRIC COMPANY: PRODUCT PORTFOLIO
TABLE 053. GENERAL ELECTRIC COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. SIEMENS HEALTHINEERS: SNAPSHOT
TABLE 054. SIEMENS HEALTHINEERS: BUSINESS PERFORMANCE
TABLE 055. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
TABLE 056. SIEMENS HEALTHINEERS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. KONINKLIJKE PHILIPS N.V.: SNAPSHOT
TABLE 057. KONINKLIJKE PHILIPS N.V.: BUSINESS PERFORMANCE
TABLE 058. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 059. KONINKLIJKE PHILIPS N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. TOSHIBA MEDICAL SYSTEMS CORPORATION: SNAPSHOT
TABLE 060. TOSHIBA MEDICAL SYSTEMS CORPORATION: BUSINESS PERFORMANCE
TABLE 061. TOSHIBA MEDICAL SYSTEMS CORPORATION: PRODUCT PORTFOLIO
TABLE 062. TOSHIBA MEDICAL SYSTEMS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. SHIMADZU CORPORATION: SNAPSHOT
TABLE 063. SHIMADZU CORPORATION: BUSINESS PERFORMANCE
TABLE 064. SHIMADZU CORPORATION: PRODUCT PORTFOLIO
TABLE 065. SHIMADZU CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. HITACHI MEDICAL CORPORATION: SNAPSHOT
TABLE 066. HITACHI MEDICAL CORPORATION: BUSINESS PERFORMANCE
TABLE 067. HITACHI MEDICAL CORPORATION: PRODUCT PORTFOLIO
TABLE 068. HITACHI MEDICAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 068. ELEKTA AB: SNAPSHOT
TABLE 069. ELEKTA AB: BUSINESS PERFORMANCE
TABLE 070. ELEKTA AB: PRODUCT PORTFOLIO
TABLE 071. ELEKTA AB: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 071. TRISTAN TECHNOLOGIES: SNAPSHOT
TABLE 072. TRISTAN TECHNOLOGIES: BUSINESS PERFORMANCE
TABLE 073. TRISTAN TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 074. TRISTAN TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 074. INC.: SNAPSHOT
TABLE 075. INC.: BUSINESS PERFORMANCE
TABLE 076. INC.: PRODUCT PORTFOLIO
TABLE 077. INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 077. NATUS MEDICAL INCORPORATED: SNAPSHOT
TABLE 078. NATUS MEDICAL INCORPORATED: BUSINESS PERFORMANCE
TABLE 079. NATUS MEDICAL INCORPORATED: PRODUCT PORTFOLIO
TABLE 080. NATUS MEDICAL INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 080. MAGSTIM: SNAPSHOT
TABLE 081. MAGSTIM: BUSINESS PERFORMANCE
TABLE 082. MAGSTIM: PRODUCT PORTFOLIO
TABLE 083. MAGSTIM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 083. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 084. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 085. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 086. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. NEUROTECHNOLOGY MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. NEUROTECHNOLOGY MARKET OVERVIEW BY PRODUCT TYPE
FIGURE 012. LINEAR STAPLERS MARKET OVERVIEW (2016-2028)
FIGURE 013. CIRCULAR STAPLERS MARKET OVERVIEW (2016-2028)
FIGURE 014. SKIN STAPLERS MARKET OVERVIEW (2016-2028)
FIGURE 015. ENDOSCOPIC STAPLERS MARKET OVERVIEW (2016-2028)
FIGURE 016. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 017. NEUROTECHNOLOGY MARKET OVERVIEW BY TECHNOLOGY
FIGURE 018. MANUAL MARKET OVERVIEW (2016-2028)
FIGURE 019. POWERED MARKET OVERVIEW (2016-2028)
FIGURE 020. NEUROTECHNOLOGY MARKET OVERVIEW BY USABILITY
FIGURE 021. DISPOSABLE MARKET OVERVIEW (2016-2028)
FIGURE 022. REUSABLE MARKET OVERVIEW (2016-2028)
FIGURE 023. NEUROTECHNOLOGY MARKET OVERVIEW BY APPLICATION
FIGURE 024. GENERAL SURGERY MARKET OVERVIEW (2016-2028)
FIGURE 025. ABDOMINAL & PELVIC SURGERY MARKET OVERVIEW (2016-2028)
FIGURE 026. CARDIAC & THORACIC SURGERY MARKET OVERVIEW (2016-2028)
FIGURE 027. ORTHOPEDIC SURGERY MARKET OVERVIEW (2016-2028)
FIGURE 028. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 029. NORTH AMERICA NEUROTECHNOLOGY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. EUROPE NEUROTECHNOLOGY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 031. ASIA PACIFIC NEUROTECHNOLOGY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 032. MIDDLE EAST & AFRICA NEUROTECHNOLOGY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 033. SOUTH AMERICA NEUROTECHNOLOGY MARKET OVERVIEW BY COUNTRY (2016-2028)